TITLE

Other News To Note

PUB. DATE
May 2013
SOURCE
BioWorld Today;5/14/2013, Vol. 24 Issue 92, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs in the pharmaceutical industry as of May 2013. Biogen idec Inc. of Weston, Massachusetts, said the U.S. Food andl Drug Administration (FDA) accepted the firm's application for Eloctate in treating Hemophilia A. The Nasdaq OMX Group Inc. of New York reported semi-annual re-ranking of Nasdaq Biotechnology Index. Pluristem Therapeutics Inc. of Haifa, Israel, said testing of Placental expanded cells effectively improved several parameters of preeclampsia.
ACCESSION #
87606224

 

Related Articles

  • FDA Clinical Hold on PLX Safety Study Trips Pluristem. Powers, Marie // BioWorld Today;6/5/2013, Vol. 24 Issue 107, p1 

    The article reports on the 14.4% decrease in stocks of Pluristem Therapeutics Inc. amid the decision of the U.S. Food and Drug Administration (FDA) to stop the U.S. Phase II study of its Placental expanded cell therapy. Zami Aberman, chairman and chief executive officer of the biotechnology...

  • NEWS IN BRIEF.  // Nature Reviews Drug Discovery;Mar2004, Vol. 3 Issue 3, p194 

    The article presents pharmaceutical industry news briefs for March 2004. The U.S. Food and Drug Administration (FDA) approved biopharmaceutical company ImClone's product cetuximab (Erbitux) for colon cancer treatment. A U.S. court of appeals upheld a previous ruling stating that the University...

  • FDA May Ease Rules For Alzheimer's Drugs.  // Chain Drug Review;4/22/2013, Vol. 35 Issue 7, p264 

    The article offers news briefs related to pharmaceutical industry as of April 22, 2013 on topics including rules revision by the U.S. Food and Drug Administration (FDA) on Alzheimer's drugs, warning by FDA on antibiotic azithromycin and transparency on pharmacists in Kentucky.

  • FDA Focuses On Safety From Global Perspective.  // Chain Drug Review;5/21/2012, Vol. 34 Issue 9, p60 

    The article offers news briefs related to the U.S. pharmaceutical industry on topics including a report released by Food and Drug Administration agency, statistics released by Scripts Inc. related to prescriptive drugs, a buyout offer by GlaxoSmithKline PLC.

  • Pharma: Other News To Note.  // BioWorld Today;5/24/2013, Vol. 24 Issue 100, p11 

    This section offers news briefs on the pharmaceutical industry as of May 2013, including the marketing authorization granted for Vesomni drug of Astellas Pharma Europe BV, the vote of the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Committee in the favor...

  • FDA Approvals In March.  // BioWorld Insight;4/15/2013, Vol. 21 Issue 16, p7 

    A table is presented which lists several drugs approved by the U.S. Food and Drug Administration along with their companies including Biogen Idec Inc, Cangene Corp and Genentech Inc.

  • Biogen Idec storms haemophilia markets.  // Nature Reviews Drug Discovery;Jul2014, Vol. 13 Issue 7, p485 

    The article reports on the approval of the drug Eloctate from Biogen Idec Inc. by the U.S. Food and Drug Administration (FDA) which is for adults and children with haemophilia A.

  • ReFacto Lessens The Risk Of Viral Transmission.  // RN;Sep2000, Vol. 63 Issue 9, p118 

    Informs on the United States Food and Drug Administration's approval of ReFacto for the control and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency). Less risk of viral transmission.

  • Wound Care: Treatment Update.  // McKnight's Long-Term Care News;Apr2011, Vol. 32 Issue 4, p8 

    The article offers news briefs related to the medical care industry of the U.S. which include the partnership of Pluristem Therapeutics Inc. with NYU Medical Center, MIST Ultrasound Healing Therapy of Celleration Inc., and the approval of Derma Sciences Inc.'s MediHoney Gel Wound and Burn...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics